Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging

Clinical Cancer Research

Volumn 6, Issue 9, 2000, Pages 3552-3559

  Bauer, K D ^a   De la Torre Bueno, J ^a   Diel, I J ^a   Hawes, D ^a   Decker, W J ^a   Priddy, C ^a   Bossy, B ^a   Ludmann, S ^a   Yamamoto, K ^a   Masih, A S ^a   Espinoza, F P ^a   Harrington, D S ^a  

^a ChromaVision Medical Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW METASTASIS; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MICROSCOPY; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REPRODUCIBILITY;

BONE MARROW NEOPLASMS; BREAST NEOPLASMS; CARCINOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICROSCOPY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING;

EID: 0033822690     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
2. Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastases
3. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
4. Tumor cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up
5. Cytokeratin-positive cells in the bone marrow and survival of patients with stage, I, II, or III breast cancer
6. Prognostic significance of micrometastatic tumor cells in the bone marrow of colorectal cancer patients
7. Immunocytological detection of bone marrow micrometastases in operable non-small cell lung cancer
8. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal cancer
9. Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients
10. Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis
11. Meta-analysis of studies of bone marrow micrometastases: An independent prognostic impact remains to be substantiated
12. Prognostic significance of micrometastatic bone marrow involvement
13. Detection and clinical importance of micrometastatic disease
14. Standardization of the immunocytochemical detection of cancer cells in bone marrow and blood. I. Establishment of objective criteria for the evaluation of immunostained cells
15. Automated screening of bone marrow smears for micrometastasis
16. Detection of immunocytochemically stained rare events using image analysis
17. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system
18. Monoclonal antibodies against human breast cancer
19. Monoclonal antibodies reactive with tumor-associated epitopes of breast mucin glycoproteins
20. Immunoscintigraphy of human mammary carcinoma xenografts using monoclonal antibodies 12H12 and BM-2 labeled with 99mTc and radioiodine
21. Detection of bone marrow breast carcinoma metastasis using multiparameter flow cytometry
22. Improved detection of rare CALLA-positive cells in peripheral blood using multiparameter flow cytometry
23. 7
24. Detection and clinical relevance of micrometastatic cancer cells
25. Molecular detection of micrometastases and circulating tumor cells in solid tumors
26. Utilization of polymerase chain reaction technology in the detection of solid tumors
27. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination
28. Limitations of reverse-transcriptase polymerase chain reaction for detection of micrometastatic epithelial cells in bone marrow
29. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
30. Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow
31. Immunocytochemical detection of isolated epithelial cells in bone marrow: Nonspecific staining and contribution by plasma cells directly reactive to alkaline phosphatase
32. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
33. Isolated tumor cells in the bone marrow: Value of a new diagnostic method in the TNM-staging of solid tumors